Delivery Order SPE2DB22D2108-SPE2DB24FU4FH

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Vimpat 100 mg tablets. The $1,490.52 firm-fixed-price Delivery Order has a completion date of January 3, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for supplying a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vimpat 100 mg tablets. The $1,415.46 firm fixed-price contract has an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,416.50 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 200ml vials of the medication Vimpat 10mg/ml solution, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for 4,563,731,927 tablets of Vimpat 200 mg, a brand name medication. The potential value of the contract is $1,250.80, with a completion date of February 22, 2024. This award is not associated with any set-aside...
This federal contract award, valued at $1,737.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the provision of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $1,328.28 contract is for the supply of Vimpat 10 mg/ml solution in 200 ml bottles. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as a single awardee, with a potential value up to...
This federal contract award is for the delivery of Vimpat 10 mg/ml solution in 200 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,688.80, was awarded to the prime contractor Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award, valued at $1,002.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery order of 4564829222 VIMPAT 150 MG TABLET 60S, a pharmaceutical product. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,972.68 firm fixed-price delivery order is for the supply of VIMPAT 200 MG TABLET 60S, a medication. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $1,600.68, this order is for 200ml of Vimpat 10mg/ml solution to be delivered by October 31, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with no set aside designation used. As a prime contractor supporting DLA Troop Support Medical programs,...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4FH
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the provision of Vimpat 150 mg Tablets to the Defense Logistics Agency (DLA). The $1,504.14 firm fixed-price delivery order contract has a completion date of June 18, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen's extensive experience in pharmaceutical distribution and supply chain management for government agencies has enabled it to secure these significant federal contracts to support the medical needs of the U.S. Armed Forces and other government entities.

Generated 9/16/24, 10:38 AM